Effects of Fuzheng Yiqing decoction in early intervention for preventing and treating COVID-19 in close contacts: a randomized controlled trial

Phase 1

Recruiting

• Conditions: ovel Coronavirus Pneumonia

• Registration Number: ITMCTR2100005142
• Lead Sponsor: China Academy of Chinese Medical Sciences; Jiangsu Privince Hospital of Chinese Medicine; Yangzhou Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.COVID-19 close contacts at centralized isolation sites;
2.Age >= 18 years;
3.Agree to participate in the trial, and the patient or the legal guardian signed the informed consent through paper signature, electronic signature of mobile phone software, or voice authorization.

Exclusion Criteria

1.Close contacts who can not guarantee compliance of using TCM during the treatment period, or close contacts who are difficult to take medicine by oral or nasal route;
2.Close contacts with severe primary respiratory disease;
3.Pregnant or parturient women. Patient who have a pregnancy plan or a positive urine pregnancy test;
4.Close contacts with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the trial;
5.Close contacts who once have been allergic or intolerant to taking TCM.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of positive 2019-nCoV RNA test;

Secondary Outcome Measures

Name	Time	Method
Symptoms;Body temperature;Patients status after the COVID-19 confirmed diagnosis;